Potvin B, Gooder H
Biochem Genet. 1975 Feb;13(1-2):125-43. doi: 10.1007/BF00486011.
In vitro and "in situ" assays have been developed to test the carbamyl phosphate synthetase (CPSase) activity of a series of pyrimidine-requiring mutants of Bacillus subtilis. The enzyme has been shown to be highly unstable, and was successfully extracted only in the presence of 10% glycerol and 1 mM dithiothreitol (Cleland's reagent). It loses activity rapidly when sonicated or when treated with lysozyme. Genetic studies, using mutants, indicate that B. subtilis may possess two CPSases. This possibility and its physiological consequences were probed enzymatically. CPSase activity has been shown to undergo inhibition by both uridine triphosphate and dihydroorotate; activation has been demonstrated in response to phosphoribosyl pyrophosphate (PRPP) and (to a lesser extent) ornithine.
已开发出体外和“原位”测定法,以测试一系列枯草芽孢杆菌嘧啶需求突变体的氨甲酰磷酸合成酶(CPSase)活性。该酶已被证明高度不稳定,仅在存在10%甘油和1 mM二硫苏糖醇(Cleland试剂)的情况下才能成功提取。当进行超声处理或用溶菌酶处理时,它会迅速失去活性。利用突变体进行的遗传学研究表明,枯草芽孢杆菌可能拥有两种CPSase。通过酶学方法探究了这种可能性及其生理后果。已表明CPSase活性会受到三磷酸尿苷和二氢乳清酸的抑制;已证明对磷酸核糖焦磷酸(PRPP)和(程度较小的)鸟氨酸有激活作用。